Advancing the utilization of real-world data in Japan’s pharmaceutical landscape through electronic health records: an interview with Takayuki Imaeda and Kanae Togo, Pfizer Japan
The Evidence Base
Register with The Evidence Base for free to access this content
By registering with The Evidence Base, you will receive our weekly round-up and other relevant editorial content. You can opt-out at any time. View our privacy policy here.